Those conditions include the sale of a UTC facility in Danbury.
anti-trust
Feds likely to approve of Raytheon, UTC deal
Although it would boost defense industry consolidation, there is little overlap between Raytheon and UTC that would pose anti-trust issues for the federal government.
Blumenthal dines with Zuckerberg to discuss Facebook regulations
“It’s no secret that I’ve been a tough critic of Facebook, so I was glad for the opportunity to discuss my concerns directly with Mr. Zuckerberg,” Blumenthal said.
CT joins multi-state investigation into Google
Attorney General William Tong and his fellow attorneys general say Google threatens competition and hurts consumers and business.
Pentagon to take a ‘hard look’ at Raytheon, UTC tie up
There are also grumblings in Congress about the deal, which would further consolidate the defense industry.
Anthem not giving up on Cigna merger, is appealing to Supreme Court
Updated at 2 p.m.
WASHINGTON — Anthem’s $54 billion merger deal with Cigna is considered to be on life support after a federal appeals court ruled last week it violated antitrust law. But on Friday, Anthem said it is appealing that decision to the U.S. Supreme Court.
Anthem’s cost savings at center of merger suit appeal argument
WASHINGTON — Anthem and the Justice Department faced off in court Friday over the insurer’s proposed merger with Cigna, with the legal wrangling centered on whether any savings from the deal would justify shrinking the market for large employer insurance policies from four to three carriers.
Anthem sues to stop Cigna from ending merger attempt
WASHINGTON — The messy divorce between Anthem and Cigna took another turn Wednesday in a Delaware court that will be the scene of further expensive legal battling over the insurers’ merger attempt.
Cigna sues to end merger deal, seeks $15 billion from Anthem
WASHINGTON — The tumultuous relationship between proposed merger partners Anthem and Cigna continued Tuesday as Cigna called for an end to the deal and demanded about $15 billion from Anthem – which said it is “committed to closing the transaction.”
Aetna ends bid to acquire Humana
WASHINGTON — After a federal judge blocked the deal last month, Aetna on Tuesday announced it would no longer pursue a $37 billion merger with Humana. U.S. District Judge John Bates ruled last month that a merger of the health insurers would result in a lack of competition in the Medicare Advantage market.
Anthem will appeal judge’s decision to block merger with Cigna
WASHINGTON — Anthem said Thursday it will appeal a federal court’s decision to block the health insurer’s planned merger with Cigna. The decision to appeal came quickly on the heels of U.S. District Judge Amy Berman Jackson’s ruling late Wednesday that the $54 billion merger would reduce competition in dozens of insurance markets across the nation.
Judge blocks Aetna-Humana merger
Updated at 4:35 p.m.
WASHINGTON — A federal judge on Monday rejected a proposed merger between Aetna and Humana, saying the $37 billion deal would “be likely to substantially lessen competition” in the Medicare Advantage market. Aetna is considering an appeal.
Aetna-Humana antitrust trial wraps up before questioning judge
WASHINGTON — The antitrust trial over a proposed merger between Aetna and Humana wrapped up Wednesday, with U.S. District Court Judge John Bates asking probing questions of both Justice Department lawyers seeking to block the deal and attorneys for the insurers defending their plan.
Cigna distances itself from Anthem at key point in merger trial
WASHINGTON — Hostilities between proposed merger partners Anthem and Cigna were on full display Tuesday at a key point of a U.S. antitrust trial over the deal. Cigna attorney Rick Rule said the company did not sign a key closing document because it did not agree with Anthem’s characterizations of the testimony of certain Cigna witnesses.
Aetna, Humana defend merger plans in court
Updated at 4:57 p.m.
WASHINGTON — Opening salvos were fired Monday in the antitrust case against the proposed merger of Aetna and Humana, with Justice Department attorneys arguing the tie-up would mean sharp price hikes for Medicare Advantage plans and a disintegration of choice for people purchasing insurance on Affordable Care Act exchanges.